Cartesian Therapeutics Inc (RNAC)

In the last 90 days, Cartesian Therapeutics Inc. saw two insider transactions, both sales totaling $257,878.74. Notably, Milos Miljkovic, a former affiliate, made two proposed sales in June 2026. The company's stock has declined 15.6% over the past 90 days. The last earnings report missed expectations by 35.7%.
Stock chart
Ticker: RNAC Exchange: NMS


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
MILOS MILJKOVIC
Former Affiliate
1 sale — total 100,000 USD
Proposed sale 9 Jun 2026
Value US$2,476,026.12 | Price 455.52 | Shares 32,994
Proposed sale 2 Jun 2026
Value US$127,550.78 | Price 25.83 | Shares 96,165
Proposed sale 13 Jan 2026
Value US$68,940.00 | Price 7.66 | Shares 9,000
Proposed sale 9 Jan 2026
Value US$12,105.37 | Price 8.02 | Shares 1,510
Sale 6 Jan 2026
Value US$162,076.99 | Price 6.82 | Shares 23,766
Sale 6 Jan 2026
Value US$24,366.79 | Price 6.82 | Shares 3,573
Sale 6 Jan 2026
Value US$72,227.44 | Price 6.82 | Shares 10,591
Buy 4 Dec 2025
Value US$205,797.00 | Price 6.86 | Shares 30,000
Proposed sale 19 Nov 2025
Value US$192,585.25 | Price 7.15 | Shares 26,935
Buy 11 Apr 2025
Value US$391,454.74 | Price 10.77 | Shares 36,338
Buy 11 Apr 2025
Value US$69,073.91 | Price 10.77 | Shares 6,412
Buy 10 Apr 2025
Value US$37,695.62 | Price 10.92 | Shares 3,451
Buy 10 Apr 2025
Value US$471,055.07 | Price 10.43 | Shares 45,144
Buy 10 Apr 2025
Value US$6,652.17 | Price 10.92 | Shares 609
Buy 10 Apr 2025
Value US$83,121.23 | Price 10.43 | Shares 7,966
Buy 9 Apr 2025
Value US$1,771.26 | Price 9.95 | Shares 178
Buy 9 Apr 2025
Value US$392,175.95 | Price 9.43 | Shares 41,604
Buy 9 Apr 2025
Value US$308.48 | Price 9.95 | Shares 31
Buy 9 Apr 2025
Value US$69,208.63 | Price 9.43 | Shares 7,342
Buy 20 Mar 2025
Value US$855,593.27 | Price 15.59 | Shares 54,889
Buy 19 Mar 2025
Value US$302,961.66 | Price 14.97 | Shares 20,234
Buy 18 Mar 2025
Value US$212,599.44 | Price 14.42 | Shares 14,740
Buy 14 Jan 2025
Value US$72,396.00 | Price 18.00 | Shares 4,022
Buy 13 Jan 2025
Value US$159,737.50 | Price 17.78 | Shares 8,983
Buy 13 Jan 2025
Value US$134,220.21 | Price 16.86 | Shares 7,962
Sale 6 Jan 2025
Value US$41,373.55 | Price 16.83 | Shares 2,458
Sale 6 Jan 2025
Value US$67,800.10 | Price 16.83 | Shares 4,028
Sale 6 Jan 2025
Value US$15,956.93 | Price 16.83 | Shares 948
Sale 6 Jan 2025
Value US$21,646.21 | Price 16.83 | Shares 1,286
Sale 6 Jan 2025
Value US$146,574.80 | Price 16.83 | Shares 8,708
Sale 6 Jan 2025
Value US$15,249.97 | Price 16.83 | Shares 906
Sale 3 Jan 2025
Value US$40,416.83 | Price 16.72 | Shares 2,417
Sale 3 Jan 2025
Value US$66,235.45 | Price 16.72 | Shares 3,961
Sale 3 Jan 2025
Value US$15,584.81 | Price 16.72 | Shares 932
Sale 3 Jan 2025
Value US$21,136.48 | Price 16.72 | Shares 1,264
Sale 3 Jan 2025
Value US$143,189.63 | Price 16.72 | Shares 8,563
Sale 3 Jan 2025
Value US$14,899.21 | Price 16.72 | Shares 891
Buy 23 Dec 2024
Value US$98,436.93 | Price 19.00 | Shares 5,181
Buy 20 Dec 2024
Value US$412,968.30 | Price 18.94 | Shares 21,800
Buy 19 Dec 2024
Value US$63,900.93 | Price 18.93 | Shares 3,376
Buy 19 Dec 2024
Value US$193,202.94 | Price 18.35 | Shares 10,529
Buy 19 Dec 2024
Value US$196,511.70 | Price 17.39 | Shares 11,303
Sale 10 Dec 2024
Value US$70,640.22 | Price 24.35 | Shares 2,901
Proposed sale 10 Dec 2024
Value US$70,640.22 | Price 24.35 | Shares 2,901
Sale 9 Dec 2024
Value US$117,257.35 | Price 25.83 | Shares 4,539
Sale 9 Dec 2024
Value US$157,236.29 | Price 25.26 | Shares 6,224
Proposed sale 9 Dec 2024
Value US$274,493.09 | Price 25.50 | Shares 10,763
Proposed sale 21 Nov 2024
Value US$546,559.84 | Price 16.67 | Shares 32,789
Sale 21 Nov 2024
Value US$546,559.84 | Price 16.67 | Shares 32,789
Sale 20 Nov 2024
Value US$1,809.00 | Price 18.09 | Shares 100
Sale 20 Nov 2024
Value US$96,760.72 | Price 17.28 | Shares 5,600
Proposed sale 20 Nov 2024
Value US$98,570.10 | Price 17.29 | Shares 5,700
Sale 19 Nov 2024
Value US$3,900.00 | Price 19.50 | Shares 200
Proposed sale 19 Nov 2024
Value US$3,900.00 | Price 19.50 | Shares 200
Proposed sale 18 Nov 2024
Value US$632,640.08 | Price 18.39 | Shares 34,400
Sale 18 Nov 2024
Value US$329,428.79 | Price 18.58 | Shares 17,728
Sale 18 Nov 2024
Value US$303,212.00 | Price 18.19 | Shares 16,672
Buy 18 Nov 2024
Value US$371,736.04 | Price 18.42 | Shares 20,181
Buy 18 Nov 2024
Value US$684,447.40 | Price 17.96 | Shares 38,114
Sale 15 Nov 2024
Value US$342,888.00 | Price 17.14 | Shares 20,000
Sale 15 Nov 2024
Value US$379,496.78 | Price 17.20 | Shares 22,068
Sale 15 Nov 2024
Value US$274,093.00 | Price 17.06 | Shares 16,065
Buy 15 Nov 2024
Value US$4,739,187.67 | Price 17.09 | Shares 277,246
Proposed sale 15 Nov 2024
Value US$379,496.78 | Price 17.20 | Shares 22,068
Proposed sale 15 Nov 2024
Value US$274,093.00 | Price 17.06 | Shares 16,065
Proposed sale 15 Nov 2024
Value US$342,889.00 | Price 17.14 | Shares 20,000
Sale 14 Nov 2024
Value US$564,644.50 | Price 16.13 | Shares 35,000
Sale 14 Nov 2024
Value US$68,255.60 | Price 17.06 | Shares 4,000
Sale 14 Nov 2024
Value US$357,644.52 | Price 16.33 | Shares 21,900
Sale 14 Nov 2024
Value US$297,823.75 | Price 17.02 | Shares 17,500
Sale 14 Nov 2024
Value US$303,125.55 | Price 16.34 | Shares 18,550
Buy 14 Nov 2024
Value US$377,435.62 | Price 16.97 | Shares 22,242
Buy 14 Nov 2024
Value US$1,200,720.48 | Price 16.19 | Shares 74,157
Proposed sale 14 Nov 2024
Value US$425,899.60 | Price 16.44 | Shares 25,900
Proposed sale 14 Nov 2024
Value US$600,948.89 | Price 16.67 | Shares 36,050
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-06-09 2026-06-09 PrS Proposed sale

Former Affiliate

32,994
455.52
US$2,476,026
32,994 455.52 US$2,476,026
2026-06-02 2026-06-02 PrS Proposed sale

Former Affiliate

96,165
25.83
US$127,551
96,165 25.83 US$127,551
2026-01-13 2026-01-13 PrS Proposed sale

Former Affiliate

22,935
323.78
US$3,356,299
22,935 323.78 US$3,356,299
2026-01-09 2026-01-09 PrS Proposed sale

Former Affiliate

1,510
8.02
US$12,105
1,510 8.02 US$12,105
2026-01-08 2026-01-06 S Sale

President and CEO

Executive Director
23,766 -6.8%
6.82
US$162,077
23,766 -6.8% 6.82 US$162,077
2026-01-08 2026-01-06 S Sale

Chief Medical Officer

Officer
3,573 -5.7%
6.82
US$24,367
3,573 -5.7% 6.82 US$24,367
2026-01-08 2026-01-06 S Sale

Chief Financial Officer

Officer
10,591 -8.0%
6.82
US$72,227
10,591 -8.0% 6.82 US$72,227
2025-12-08 2025-12-04 B Purchase Non-Executive Director
30,000 +123.1%
6.86
US$205,797
30,000 +123.1% 6.86 US$205,797
2025-11-19 2025-11-19 PrS Proposed sale

Former Affiliate

26,935
7.15
US$192,585
26,935 7.15 US$192,585
2025-04-11 2025-04-11 B Purchase Non-Executive Director Large shareholder
36,338 +5.9%
10.77
US$391,455
36,338 +5.9% 10.77 US$391,455
2025-04-11 2025-04-11 B Purchase Non-Executive Director Large shareholder
6,412 +0.1%
10.77
US$69,074
6,412 +0.1% 10.77 US$69,074
2025-04-11 2025-04-10 B Purchase Non-Executive Director Large shareholder
3,451 +0.6%
10.92
US$37,696
3,451 +0.6% 10.92 US$37,696
2025-04-11 2025-04-10 B Purchase Non-Executive Director Large shareholder
45,144 +7.9%
10.43
US$471,055
45,144 +7.9% 10.43 US$471,055
2025-04-11 2025-04-10 B Purchase Non-Executive Director Large shareholder
609 +0.0%
10.92
US$6,652
609 +0.0% 10.92 US$6,652
2025-04-11 2025-04-10 B Purchase Non-Executive Director Large shareholder
7,966 +0.1%
10.43
US$83,121
7,966 +0.1% 10.43 US$83,121
2025-04-11 2025-04-09 B Purchase Non-Executive Director Large shareholder
178 +0.0%
9.95
US$1,771
178 +0.0% 9.95 US$1,771
2025-04-11 2025-04-09 B Purchase Non-Executive Director Large shareholder
41,604 +7.9%
9.43
US$392,176
41,604 +7.9% 9.43 US$392,176
2025-04-11 2025-04-09 B Purchase Non-Executive Director Large shareholder
31 +0.0%
9.95
US$308
31 +0.0% 9.95 US$308
2025-04-11 2025-04-09 B Purchase Non-Executive Director Large shareholder
7,342 +0.1%
9.43
US$69,209
7,342 +0.1% 9.43 US$69,209
2025-03-20 2025-03-20 B Purchase Non-Executive Director Large shareholder
54,889 +0.6%
15.59
US$855,593
54,889 +0.6% 15.59 US$855,593
2025-03-20 2025-03-19 B Purchase Non-Executive Director Large shareholder
20,234 +0.2%
14.97
US$302,962
20,234 +0.2% 14.97 US$302,962
2025-03-20 2025-03-18 B Purchase Non-Executive Director Large shareholder
14,740 +0.2%
14.42
US$212,599
14,740 +0.2% 14.42 US$212,599
2025-01-15 2025-01-14 B Purchase Non-Executive Director Large shareholder
4,022 +0.0%
18.00
US$72,396
4,022 +0.0% 18.00 US$72,396
2025-01-15 2025-01-13 B Purchase Non-Executive Director Large shareholder
8,983 +0.1%
17.78
US$159,738
8,983 +0.1% 17.78 US$159,738
2025-01-15 2025-01-13 B Purchase Non-Executive Director Large shareholder
7,962 +0.1%
16.86
US$134,220
7,962 +0.1% 16.86 US$134,220
2025-01-07 2025-01-06 S Sale

Chief Technology Officer

Officer
2,458 -3.8%
16.83
US$41,374
2,458 -3.8% 16.83 US$41,374
2025-01-07 2025-01-06 S Sale

Chief Financial Officer

Officer
4,028 -4.1%
16.83
US$67,800
4,028 -4.1% 16.83 US$67,800
2025-01-07 2025-01-06 S Sale

Chief Medical Officer

Officer
948 -2.6%
16.83
US$15,957
948 -2.6% 16.83 US$15,957
2025-01-07 2025-01-06 S Sale

Chief Scientific Officer

Officer
1,286 -2.3%
16.83
US$21,646
1,286 -2.3% 16.83 US$21,646
2025-01-07 2025-01-06 S Sale

President and CEO

Executive Director
8,708 -4.1%
16.83
US$146,575
8,708 -4.1% 16.83 US$146,575
2025-01-07 2025-01-06 S Sale

Chief Operations Officer

Officer
906 -2.2%
16.83
US$15,250
906 -2.2% 16.83 US$15,250
2025-01-07 2025-01-03 S Sale

Chief Technology Officer

Officer
2,417 -3.6%
16.72
US$40,417
2,417 -3.6% 16.72 US$40,417
2025-01-07 2025-01-03 S Sale

Chief Financial Officer

Officer
3,961 -3.9%
16.72
US$66,235
3,961 -3.9% 16.72 US$66,235
2025-01-07 2025-01-03 S Sale

Chief Medical Officer

Officer
932 -2.5%
16.72
US$15,585
932 -2.5% 16.72 US$15,585
2025-01-07 2025-01-03 S Sale

Chief Scientific Officer

Officer
1,264 -2.3%
16.72
US$21,136
1,264 -2.3% 16.72 US$21,136
2025-01-07 2025-01-03 S Sale

President and CEO

Executive Director
8,563 -3.9%
16.72
US$143,190
8,563 -3.9% 16.72 US$143,190
2025-01-07 2025-01-03 S Sale

Chief Operations Officer

Officer
891 -2.1%
16.72
US$14,899
891 -2.1% 16.72 US$14,899
2024-12-23 2024-12-23 B Purchase Non-Executive Director Large shareholder
5,181 +0.1%
19.00
US$98,437
5,181 +0.1% 19.00 US$98,437
2024-12-23 2024-12-20 B Purchase Non-Executive Director Large shareholder
21,800 +0.3%
18.94
US$412,968
21,800 +0.3% 18.94 US$412,968
2024-12-23 2024-12-19 B Purchase Non-Executive Director Large shareholder
3,376 +0.0%
18.93
US$63,901
3,376 +0.0% 18.93 US$63,901
2024-12-23 2024-12-19 B Purchase Non-Executive Director Large shareholder
10,529 +0.1%
18.35
US$193,203
10,529 +0.1% 18.35 US$193,203
2024-12-23 2024-12-19 B Purchase Non-Executive Director Large shareholder
11,303 +0.1%
17.39
US$196,512
11,303 +0.1% 17.39 US$196,512
2024-12-11 2024-12-10 S Sale

Chief Technology Officer

Officer
2,901 -5.4%
24.35
US$70,640
2,901 -5.4% 24.35 US$70,640
2024-12-10 2024-12-10 PrS Proposed sale

Officer

Officer
2,901
24.35
US$70,640
2,901 24.35 US$70,640
2024-12-11 2024-12-09 S Sale

Chief Technology Officer

Officer
4,539 -8.2%
25.83
US$117,257
4,539 -8.2% 25.83 US$117,257
2024-12-11 2024-12-09 S Sale

Chief Technology Officer

Officer
6,224 -10.1%
25.26
US$157,236
6,224 -10.1% 25.26 US$157,236
2024-12-09 2024-12-09 PrS Proposed sale

Officer

Officer
10,763
25.50
US$274,493
10,763 25.50 US$274,493
2024-11-21 2024-11-21 PrS Proposed sale

Officer

Officer
32,789
16.67
US$546,560
32,789 16.67 US$546,560
2024-11-21 2024-11-21 S Sale

Chief Technology Officer

Officer
32,789 -39.1%
16.67
US$546,560
32,789 -39.1% 16.67 US$546,560
2024-11-21 2024-11-20 S Sale

Chief Technology Officer

Officer
100 -0.2%
18.09
US$1,809
100 -0.2% 18.09 US$1,809
2024-11-21 2024-11-20 S Sale

Chief Technology Officer

Officer
5,600 -9.9%
17.28
US$96,761
5,600 -9.9% 17.28 US$96,761
2024-11-20 2024-11-20 PrS Proposed sale

Officer

Officer
5,700
17.29
US$98,570
5,700 17.29 US$98,570
2024-11-21 2024-11-19 S Sale

Chief Technology Officer

Officer
200 -0.4%
19.50
US$3,900
200 -0.4% 19.50 US$3,900
2024-11-19 2024-11-19 PrS Proposed sale

Officer

Officer
200
19.50
US$3,900
200 19.50 US$3,900
2024-11-18 2024-11-18 PrS Proposed sale

Officer

Officer
34,400
18.39
US$632,640
34,400 18.39 US$632,640
2024-11-18 2024-11-18 S Sale

Chief Technology Officer

Officer
17,728 -25.8%
18.58
US$329,429
17,728 -25.8% 18.58 US$329,429
2024-11-18 2024-11-18 S Sale

Chief Technology Officer

Officer
16,672 -19.5%
18.19
US$303,212
16,672 -19.5% 18.19 US$303,212
2024-11-18 2024-11-18 B Purchase Non-Executive Director Large shareholder
20,181 +0.2%
18.42
US$371,736
20,181 +0.2% 18.42 US$371,736
2024-11-18 2024-11-18 B Purchase Non-Executive Director Large shareholder
38,114 +0.5%
17.96
US$684,447
38,114 +0.5% 17.96 US$684,447
2024-11-18 2024-11-15 S Sale

Chief Medical Officer

Officer
20,000 -52.3%
17.14
US$342,888
20,000 -52.3% 17.14 US$342,888
2024-11-18 2024-11-15 S Sale

Chief Technology Officer

Officer
22,068 -30.2%
17.20
US$379,497
22,068 -30.2% 17.20 US$379,497
2024-11-18 2024-11-15 S Sale

Chief Scientific Officer

Officer
16,065 -38.2%
17.06
US$274,093
16,065 -38.2% 17.06 US$274,093
2024-11-18 2024-11-15 B Purchase Non-Executive Director Large shareholder
277,246 +3.4%
17.09
US$4,739,188
277,246 +3.4% 17.09 US$4,739,188
2024-11-15 2024-11-15 PrS Proposed sale

Officer

Officer
22,068
17.20
US$379,497
22,068 17.20 US$379,497
2024-11-15 2024-11-15 PrS Proposed sale

Officer

Officer
16,065
17.06
US$274,093
16,065 17.06 US$274,093
2024-11-15 2024-11-15 PrS Proposed sale

Officer

Officer
20,000
17.14
US$342,889
20,000 17.14 US$342,889
2024-11-18 2024-11-14 S Sale

Chief Medical Officer

Officer
35,000 -65.7%
16.13
US$564,644
35,000 -65.7% 16.13 US$564,644
2024-11-18 2024-11-14 S Sale

Chief Technology Officer

Officer
4,000 -7.3%
17.06
US$68,256
4,000 -7.3% 17.06 US$68,256
2024-11-18 2024-11-14 S Sale

Chief Technology Officer

Officer
21,900 -28.5%
16.33
US$357,645
21,900 -28.5% 16.33 US$357,645
2024-11-18 2024-11-14 S Sale

Chief Scientific Officer

Officer
17,500 -40.3%
17.02
US$297,824
17,500 -40.3% 17.02 US$297,824
2024-11-18 2024-11-14 S Sale

Chief Scientific Officer

Officer
18,550 -29.9%
16.34
US$303,126
18,550 -29.9% 16.34 US$303,126
2024-11-18 2024-11-14 B Purchase Non-Executive Director Large shareholder
22,242 +0.3%
16.97
US$377,436
22,242 +0.3% 16.97 US$377,436
2024-11-18 2024-11-14 B Purchase Non-Executive Director Large shareholder
74,157 +0.9%
16.19
US$1,200,720
74,157 +0.9% 16.19 US$1,200,720
2024-11-14 2024-11-14 PrS Proposed sale

Officer

Officer
25,900
16.44
US$425,900
25,900 16.44 US$425,900
2024-11-14 2024-11-14 PrS Proposed sale

Officer

Officer
36,050
16.67
US$600,949
36,050 16.67 US$600,949